ABLIM2 | Actin binding LIM protein family, member 2 | Predicted intracellular proteins
| ![](/images/35808/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/35808/69058_B_8_1_rna_selected_60x60.jpg) | Tissue enhanced |
AC044839.1 | Uncharacterized protein {ECO:0000313|Ensembl:ENSP00000368055} | Predicted intracellular proteins
| ![](/images/60293/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images/60293/ihc_cell_selected_60x60.jpg) | ![](/images/60293/133747_B_9_1_rna_selected_60x60.jpg) | Tissue enhanced |
AC129492.1 | | Predicted intracellular proteins
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enhanced |
ADCY2 | Adenylate cyclase 2 (brain) | Enzymes Predicted intracellular proteins Predicted membrane proteins
| | ![](/images/38015/1291_B5_2_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/38015/84094_B_8_1_rna_selected_60x60.jpg) | Tissue enhanced |
AGBL1 | ATP/GTP binding protein-like 1 | Disease related genes Enzymes Potential drug targets Predicted intracellular proteins
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enhanced |
ALPK2 | Alpha-kinase 2 | Cancer-related genes Enzymes Predicted intracellular proteins
| ![](/images/28084/ihc_selected_60x60.jpg) | | ![](/images_static/rna_center.gif) | ![](/images/29801/63981_B_9_3_rna_selected_60x60.jpg) | Tissue enhanced |
AMIGO3 | Adhesion molecule with Ig-like domain 3 | Predicted membrane proteins
| ![](/images/26673/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/26673/56224_B_8_1_rna_selected_60x60.jpg) | Tissue enhanced |
ANK1 | Ankyrin 1, erythrocytic | Cytoskeleton related proteins Disease related genes Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | ![](/images/4842/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/56953/133861_B_1_5_rna_selected_60x60.jpg) | Tissue enhanced |
ANO5 | Anoctamin 5 | Disease related genes Predicted membrane proteins
| ![](/images/58857/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/58857/135541_B_8_5_rna_selected_60x60.jpg) | Tissue enhanced |
ASB2 | Ankyrin repeat and SOCS box containing 2 | Predicted intracellular proteins
| ![](/images/1546/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/1546/5052_B_8_5_rna_selected_60x60.jpg) | Tissue enhanced |
ASB5 | Ankyrin repeat and SOCS box containing 5 | Predicted intracellular proteins Predicted membrane proteins
| ![](/images/28870/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/28870/67654_A_2_8_rna_selected_60x60.jpg) | Tissue enhanced |
BEST3 | Bestrophin 3 | Predicted intracellular proteins Predicted membrane proteins
| ![](/images/54582/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/54582/125532_B_8_2_rna_selected_60x60.jpg) | Tissue enhanced |
C15orf27 | Chromosome 15 open reading frame 27 | Predicted membrane proteins
| ![](/images/41921/ihc_selected_60x60.jpg) | | ![](/images_static/rna_center.gif) | ![](/images/41921/92033_B_8_5_rna_selected_60x60.jpg) | Tissue enhanced |
C1orf127 | Chromosome 1 open reading frame 127 | Predicted intracellular proteins Predicted secreted proteins
| ![](/images/27654/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/27654/60562_B_8_2_rna_selected_60x60.jpg) | Tissue enhanced |
CA14 | Carbonic anhydrase XIV | Enzymes FDA approved drug targets Predicted intracellular proteins Predicted membrane proteins
| ![](/images/8482/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | | ![](/images/8482/23361_B_8_6_rna_selected_60x60.jpg) | Tissue enhanced |
CAP2 | CAP, adenylate cyclase-associated protein, 2 (yeast) | Cancer-related genes Predicted intracellular proteins
| | ![](/images/50530/if_selected_60x60.jpg) | | ![](/images/50530/123834_B_1_7_rna_selected_60x60.jpg) | Tissue enhanced |
CAPN3 | Calpain 3, (p94) | Disease related genes Enzymes Potential drug targets Predicted intracellular proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/40052/130539_A_3_8_rna_selected_60x60.jpg) | Tissue enhanced |
CCDC28B | Coiled-coil domain containing 28B | Disease related genes Predicted intracellular proteins
| ![](/images/28589/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/28589/59593_A_4_4_rna_selected_60x60.jpg) | Tissue enhanced |
CECR2 | Cat eye syndrome chromosome region, candidate 2 | Predicted intracellular proteins
| ![](/images/2943/ihc_selected_60x60.jpg) | ![](/images/2943/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/2943/7928_B_9_4_rna_selected_60x60.jpg) | Tissue enhanced |
CEP85 | Centrosomal protein 85kDa | Predicted intracellular proteins
| ![](/images/28252/ihc_selected_60x60.jpg) | | ![](/images/28252/ihc_cell_selected_60x60.jpg) | ![](/images/28252/58400_B_8_5_rna_selected_60x60.jpg) | Tissue enhanced |
CFAP46 | Cilia and flagella associated protein 46 | Predicted intracellular proteins Predicted membrane proteins
| ![](/images/38034/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/37786/80447_B_7_7_rna_selected_60x60.jpg) | Tissue enhanced |
CHRNA1 | Cholinergic receptor, nicotinic, alpha 1 (muscle) | Disease related genes Predicted membrane proteins Transporters
| ![](/images/10902/ihc_selected_60x60.jpg) | | ![](/images_static/rna_center.gif) | ![](/images/10902/42722_B_9_1_rna_selected_60x60.jpg) | Tissue enhanced |
CLIC5 | Chloride intracellular channel 5 | Predicted intracellular proteins Transporters
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enhanced |
CLTCL1 | Clathrin, heavy chain-like 1 | Cancer-related genes Plasma proteins Predicted intracellular proteins
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enhanced |
CORO6 | Coronin 6 | Predicted intracellular proteins
| ![](/images/21556/ihc_selected_60x60.jpg) | | ![](/images_static/rna_center.gif) | ![](/images/21556/48471_A_7_4_rna_selected_60x60.jpg) | Tissue enhanced |
CTD-2207O23.12 | Uncharacterized protein {ECO:0000313|Ensembl:ENSP00000469588} | Predicted intracellular proteins
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enhanced |
DGCR6 | DiGeorge syndrome critical region gene 6 | Predicted intracellular proteins
| ![](/images/47905/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/47905/113401_B_8_1_rna_selected_60x60.jpg) | Tissue enhanced |
DUSP26 | Dual specificity phosphatase 26 (putative) | Enzymes Predicted intracellular proteins
| ![](/images/18221/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/18221/41715_B_7_3_rna_selected_60x60.jpg) | Tissue enhanced |
EEF1A2 | Eukaryotic translation elongation factor 1 alpha 2 | Plasma proteins Predicted intracellular proteins
| ![](/images/51759/ihc_selected_60x60.jpg) | ![](/images/56990/968_G8_1_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/53862/130007_B_7_4_rna_selected_60x60.jpg) | Tissue enhanced |
EXTL1 | Exostosin-like glycosyltransferase 1 | Enzymes Predicted secreted proteins
| ![](/images/37749/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/37749/85733_B_8_1_rna_selected_60x60.jpg) | Tissue enhanced |
FAM184B | Family with sequence similarity 184, member B | Predicted intracellular proteins
| ![](/images/44119/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/44119/103058_B_3_5_rna_selected_60x60.jpg) | Tissue enhanced |
FLNC | Filamin C, gamma | Cytoskeleton related proteins Disease related genes Plasma proteins Predicted intracellular proteins
| | | ![](/images_static/rna_center.gif) | ![](/images/6135/18413_B_9_3_rna_selected_60x60.jpg) | Tissue enhanced |
FNDC5 | Fibronectin type III domain containing 5 | Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/51290/116815_B_5_3_rna_selected_60x60.jpg) | Tissue enhanced |
FZD9 | Frizzled class receptor 9 | CD markers G-protein coupled receptors Predicted membrane proteins
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enhanced |
GRIP2 | Glutamate receptor interacting protein 2 | Predicted intracellular proteins
| ![](/images_static/rna_center.gif) | ![](/images/35673/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enhanced |
HOXC10 | Homeobox C10 | Predicted intracellular proteins Transcription factors
| ![](/images/53919/ihc_selected_60x60.jpg) | | ![](/images_static/rna_center.gif) | ![](/images/53919/136216_B_8_1_rna_selected_60x60.jpg) | Tissue enhanced |
HOXC9 | Homeobox C9 | Predicted intracellular proteins Transcription factors
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enhanced |
HSPB2 | Heat shock 27kDa protein 2 | Predicted intracellular proteins
| ![](/images/38889/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/38889/83408_A_8_8_rna_selected_60x60.jpg) | Tissue enhanced |
HSPB6 | Heat shock protein, alpha-crystallin-related, B6 | Predicted intracellular proteins
| | ![](/images_static/na_center.gif) | | ![](/images/54811/135207_B_1_7_rna_selected_60x60.jpg) | Tissue enhanced |
HSPB7 | Heat shock 27kDa protein family, member 7 (cardiovascular) | Predicted intracellular proteins
| ![](/images/27639/ihc_selected_60x60.jpg) | ![](/images/27639/1446_A2_3_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/27639/58843_B_9_1_rna_selected_60x60.jpg) | Tissue enhanced |
IL17D | Interleukin 17D | Predicted secreted proteins
| ![](/images/60475/ihc_selected_60x60.jpg) | ![](/images/60475/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/60475/135912_B_8_3_rna_selected_60x60.jpg) | Tissue enhanced |
IP6K3 | Inositol hexakisphosphate kinase 3 | Enzymes Predicted intracellular proteins
| ![](/images/53644/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images/53644/ihc_cell_selected_60x60.jpg) | ![](/images/53644/130560_A_1_6_rna_selected_60x60.jpg) | Tissue enhanced |
JPH2 | Junctophilin 2 | Disease related genes Predicted intracellular proteins Predicted membrane proteins
| ![](/images/52646/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/52646/122640_B_8_2_rna_selected_60x60.jpg) | Tissue enhanced |
KCNJ11 | Potassium inwardly-rectifying channel, subfamily J, member 11 | Disease related genes FDA approved drug targets Predicted membrane proteins Voltage-gated ion channels
| ![](/images/48891/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/48891/121832_B_9_3_rna_selected_60x60.jpg) | Tissue enhanced |
KCNJ18 | Potassium inwardly-rectifying channel, subfamily J, member 18 | Predicted membrane proteins
| ![](/images/27021/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/27021/61112_A_2_6_rna_selected_60x60.jpg) | Tissue enhanced |
KCNS3 | Potassium voltage-gated channel, delayed-rectifier, subfamily S, member 3 | Predicted intracellular proteins Predicted membrane proteins Transporters Voltage-gated ion channels
| ![](/images/14864/ihc_selected_60x60.jpg) | ![](/images/14864/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/14864/33788_B_9_4_rna_selected_60x60.jpg) | Tissue enhanced |
KLHL30 | Kelch-like family member 30 | Predicted intracellular proteins
| ![](/images/45926/ihc_selected_60x60.jpg) | ![](/images/62095/1416_E11_2_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/45926/103125_B_9_2_rna_selected_60x60.jpg) | Tissue enhanced |
LINGO4 | Leucine rich repeat and Ig domain containing 4 | Predicted membrane proteins
| ![](/images/60781/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/60781/134562_B_8_3_rna_selected_60x60.jpg) | Tissue enhanced |
LMCD1 | LIM and cysteine-rich domains 1 | Predicted intracellular proteins
| ![](/images/24059/53925_B_2_6_selected_60x60.jpg) | ![](/images/24059/if_selected_60x60.jpg) | ![](/images/24059/ihc_cell_selected_60x60.jpg) | ![](/images/24059/53924_B_7_7_rna_selected_60x60.jpg) | Tissue enhanced |
MACROD1 | MACRO domain containing 1 | Disease related genes Predicted intracellular proteins
| ![](/images/41031/ihc_selected_60x60.jpg) | | ![](/images_static/rna_center.gif) | ![](/images/41031/91199_B_3_2_rna_selected_60x60.jpg) | Tissue enhanced |